[Federal Register Volume 66, Number 241 (Friday, December 14, 2001)]
[Notices]
[Page 64810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-30844]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Defense Science Board; Meetings

AGENCY: Department of Defense.

ACTION: Notice of advisory committee meetings.

-----------------------------------------------------------------------

SUMMARY: The Defense Science Board (DSB) Task Force on Defense Against 
Terrorists' Use of Biological Weapons will meet in closed session on 
February 18-19, 2002; March 11-12, 2002; April 1-2, 2002; April 29-30, 
2002; June 3-4, 2002; June 24-25, 2002; and July 22-23, 2002, at 
Strategic Analysis Inc., 3601 Wilson Boulevard, Arlington, VA. This 
Task Force will assess the scope of activities conducted by the DoD to 
ensure its future preparedness to deter, defend against, respond to, 
and attribute attack of the U.S. homeland by terrorists using 
biological weapons.
    The mission of the Defense Science Board is to advise the Secretary 
of Defense and the Under Secretary of Defense for Acquisition, 
Technology & Logistics on scientific and technical matters as they 
affect the perceived needs of the Department of Defense. At these 
meetings, the Task Force will conduct an assessment of the most 
probable biological threats and the implications of new technologies on 
the threat spectrum, deterrence and consequence management; identify 
new technologies to provide satisfactory surveillance and verification 
of known and emerging diseases to ensure implementation of proactive 
defense measures and event mitigation; identify reliable and effective 
vaccines, anti-viral drugs and antibiotics, including the availability 
of sufficient vaccine and drug manufacturing capacity; determine 
logistical adequacy of the current supply chain for drug and vaccine 
production; identify capabilities to achieve reliable attribution of 
attackers once a BW attack has occurred; and identify defense 
capabilities and postures that have the largest potential for 
comprehensive protection of military and civilian targets.
    In accordance with section 10(d) of the Federal Advisory Committee 
Act, Pub. L. 92-463, as amended (5 U.S.C. App. II), it has been 
determined that these Defense Science Board Task Force meetings concern 
matters listed in 5 U.S.C. 552b(c)(1) and that, accordingly, these 
meetings will be closed to the public.

    Dated: December 7, 2001.
L.M. Bynum,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 01-30844 Filed 12-13-01; 8:45 am]
BILLING CODE 5001-08-M